OSE Pharma SA Tangible Net Worth Ratio
OSE Pharma SA tangible net worth ratio. OSE Pharma SA (OSE) has a Tangible Net Worth Ratio of 15.3% as of June 2025. This metric is calculated by deducting intangible assets (€42.84 Million) from net assets (€50.60 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check OSE Pharma SA strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of OSE Pharma SA (2015–2024)
Tangible net worth ratio of OSE Pharma SA from 2015 to 2024. This chart shows how OSE Pharma SA's Tangible Net Worth Ratio has changed across 10 annual periods from 2015 to 2024. As of June 2025, the ratio stands at 15.3%, reflecting net assets of €50.60 Million with intangible assets of €42.84 Million EUR. See OSE net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
OSE Pharma SA Tangible Net Worth Ratio by Year (2015–2024)
OSE Pharma SA tangible net worth ratio by year from 2015 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for OSE Pharma SA from 2015 to 2024, covering 10 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see OSE Pharma SA market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 31.0% | €63.81 Million | €44.01 Million | €123.96 Million | ▲ +133.0 pp |
| 2023 | -102.0% | €22.98 Million | €46.40 Million | €82.05 Million | ▼ -52.1 pp |
| 2022 | -49.9% | €32.55 Million | €48.78 Million | €91.67 Million | ▼ -42.3 pp |
| 2021 | -7.5% | €47.53 Million | €51.12 Million | €101.52 Million | ▼ -21.7 pp |
| 2020 | 14.1% | €61.24 Million | €52.60 Million | €96.85 Million | ▲ +4.0 pp |
| 2019 | 10.1% | €58.49 Million | €52.60 Million | €88.89 Million | ▼ -4.7 pp |
| 2018 | 14.8% | €61.75 Million | €52.60 Million | €76.90 Million | ▲ +9.7 pp |
| 2017 | 5.1% | €55.45 Million | €52.60 Million | €77.35 Million | ▼ -13.3 pp |
| 2016 | 18.5% | €64.53 Million | €52.60 Million | €89.55 Million | ▼ -81.5 pp |
| 2015 | 100.0% | €14.48 Million | €0.00 | €17.00 Million | — |